The objective of this study was to determine if the omission of GnRH at controlled internal drug release device (CIDR) insertion would impact pregnancy rates to timed AI (TAI) in beef heifers enrolled in a 5-d CO-Synch + CIDR protocol that used 1 PGF 2α dose given at CIDR removal. Yearling beef heifers in Ohio in 2 consecutive breeding seasons (2011, n = 151, and 2012, n = 143; Angus × Simmental), Utah (2012, n = 265; Angus × Hereford), Idaho (2012, n = 127; Charolais), and Wyoming (2012, n = 137; Angus) were enrolled in the 5-d CO-Synch + CIDR protocol. At CIDR insertion (d -5), heifers were randomly assigned either to receive 100 μg GnRH (GnRH+; n = 408) or not to receive GnRH (GnRH-; n = 415). At CIDR removal (d 0 of the experiment), 25 mg PGF 2α was administered to all heifers. All heifers were inseminated by TAI and given 100 μg GnRH 72 h after PGF 2α (d 3). In heifers at the Ohio locations (n = 294), presence of a corpus luteum (CL) at CIDR insertion (d -5) was determined via assessment of progesterone concentrations (2011) and ovarian ultrasonography (2012). Subsequently, in both years, ovarian ultrasound was conducted on d 0 to determine the presence of a new CL. In this same subgroup of heifers, blood samples for progesterone analysis were collected on d 3 to assess luteal regression. Pregnancy diagnosis was performed between 32 and 38 d after TAI. At CIDR withdrawal, presence of a new CL was greater (P < 0.05) in the GnRH+ (55.8%, 82/147) than GnRH-(26.5%, 39/147) treatment. Incidence of failed luteal regression did not differ between the GnRH+ (3.4%) and GnRH-(0.7%) treatments. Pregnancy rate to TAI did not differ between the GnRH+ (50.5%) and GnRH-(54.9%) treatments. In conclusion, although the incidence of a new CL at CIDR removal was increased in the GnRH+ treatment, omission of the initial GnRH treatment in the 5-d CO-Synch + CIDR protocol did not influence TAI pregnancy rate in yearling beef heifers. In addition, a single dose of PGF 2α at CIDR removal was effective at inducing luteolysis in yearling beef heifers enrolled in the 5-d CO-Synch + CIDR protocol, regardless of whether or not the initial GnRH treatment was given.
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INTRODUCTION
The 5-d CO-Synch + controlled internal drug release (CIDR) protocol has been demonstrated as an effective protocol for synchronizing ovulation in beef and dairy cattle (Bridges et al., 2008; Santos et al., 2010; Rabaglino et al., 2010a) . The standard 5-d protocol includes an initial administration of GnRH (GnRH-1) at insertion of an intravaginal progesterone releasing device (CIDR) followed 5 d later by 2 doses of PGF 2α , given approximately 8 h apart, and CIDR removal and timed AI (TAI) with a second GnRH (GnRH-2) 72 h after PGF 2α . This approach has achieved TAI pregnancy rates varying from 46.1 to 62.5% in dairy and beef heifers (Rabaglino et al., 2010a; Lima et al., 2011 Lima et al., , 2013 Peterson et al., 2011; Perry et al., 2012) .
Despite acceptable TAI pregnancy rates with the 5-d protocol, questions remain relative to the necessity of GnRH-1 and PGF 2α requirements. Although Lima et al. (2011) reported that omitting GnRH-1 did not decrease pregnancy rates in dairy heifers, it was later reported (Lima et al., 2013 ) that TAI pregnancy rate was greater when GnRH-1 was given than when GnRH-1 was omitted. Rabaglino et al. (2010a) reported similar TAI pregnancy rates with 1 or 2 doses of PGF 2α in dairy heifers, whereas Peterson et al. (2011) reported greater TAI pregnancy rate with 2 than 1 PGF 2α dose in beef heifers. Kasimanickam et al. (2014) submitted beef and dairy heifers to the 5-d protocol where heifers either received or did not receive GnRH-1 and heifers either received 1 or 2 doses of PGF 2α . Although similar TAI pregnancy rates occurred across all combinations in dairy heifers, TAI pregnancy rates were less if GnRH-1 was omitted when compared to beef heifers that received GnRH-1 and 1 PGF 2α dose. Pregnancy rate in beef heifers that received GnRH-1 and 2 PGF 2α doses did not differ from other combinations. The objective in the present study was to determine if the omission of the GnRH-1 would impact TAI pregnancy rates in the 5-d CO-Synch + CIDR protocol in beef heifers when 1 dose of PGF 2α was used.
MATERIALS AND METHODS

Animals and Treatments
Yearling beef heifers (n = 823) from 5 locations were used in this experiment. In Ohio, Angus × Simmental heifers in 2011 (beef heifers used in Ohio in 2011 defined as Ohio-11; n = 151) were stratified to treatment by age (14.2 ± 0.04 mo) and BW (342.3 ± 3.36 kg). Beef heifers in Ohio in 2012 (Ohio-12; n = 143) were randomly assigned to treatments. Heifers described above were maintained on a roughage diet consisting of either pasture or hay and water ad libitum. Heifers used in Wyoming in 2012 (Wyoming-12; Angus; n = 137) and in Utah in 2012 (Utah-12; Angus × Hereford; n = 265), were housed in feedlot pens and assigned at random to treatments. Heifers in Idaho in 2012 (Idaho-12; Charolais; n = 127), heifers were housed in feedlot pens but stratified to treatments by BW (426.6 ± 3.66 kg). Heifers were handled in accordance with procedures approved by the Agricultural Animal Care and Use Committee from either Ohio State University, University of Wyoming, or University of Minnesota.. All heifers were submitted (Fig. 1) to the 5-d CO-Synch + CIDR protocol (CIDR; Zoetis, Florham Park, NJ). At CIDR insertion (d -5), heifers were assigned either to receive 100 μg of GnRH (GnRH+; n = 408; Factrel; Zoetis) or to not receive GnRH (GnRH-; n = 415). At CIDR removal (d 0), a single 25 mg dose of PGF 2α (Lutalyse; Zoetis) was administered to all heifers. All heifers were inseminated by TAI and given 100 μg GnRH on d 3 (72 h after PGF 2α ). In tail paint (Tell Tail; Fil Agritech, Little York, NY) was applied to all heifers at PGF 2α (n = 421). Exclusively at Ohio-11, visual estrus detection was performed twice daily (morning and evening) from CIDR removal until TAI to assess estrus distribution. At TAI, heifers receiving tail paint were scored (tail paint score [TPS] : 1 = paint completely removed, 2 = paint disturbed by mounting and partially removed, and 3 = paint largely undisturbed and no evidence of mounting) to estimate estrus response.
Ultrasonography, Blood Collection, and Radioimmunoassay
In the Ohio-11 replication, a blood sample was collected on d -5 and subsequently analyzed for concentration of progesterone (P4) to identify the presence of a corpus luteum (CL) at CIDR insertion. Heifers with P4 concentrations >1.0 ng/mL at CIDR insertion were classified as having a CL at GnRH-1 administration. At CIDR removal (d 0), transrectal ultrasonography using a 7.5 MHz linear array transducer (Aloka 500V; Aloka, Wallingford, CT) was performed to determine the presence or absence of a new CL. Although this method of assessment of ovulation to GnRH-1 would misclassify heifers that experienced double ovulation before GnRH-1 administration, the occurrence of 2 CL in randomly cycling heifers is 1 to 4% (Wiltbank et al., 2000) and, due to randomization, would be expected to be similar across treatments. Diameter of the largest ovarian follicle was also recorded on d 0 in Ohio-11. In the Ohio-12 replication, transrectal ultrasonography and a blood collection for concentrations of P4 were performed on d -5 to identify the presence of a CL at CIDR insertion and a second ultrasonography was performed on d 0 to determine the presence of a new CL at CIDR withdrawal ( Fig. 1) . In both subgroups of heifers (Ohio-11 and Ohio-12; n = 294 total), blood samples were collected for P4 analysis on d 3 (at TAI). These samples were used to estimate the proportion of heifers that failed to undergo complete luteolysis. Heifers with circulating concentrations of P4 >0.5 ng/mL on d 3 were considered to have failed to undergo luteolysis. In Ohio-11 (n = 151), blood samples were collected on d -15 and -5 for analysis of circulating concentrations of P4 for determination of pubertal status at the initiation of the synchronization protocol. Heifers were defined as pubertal when P4 were ≥1.0 ng/mL in at least 1 of these samples (d -15 or -5) . All blood samples were collected via jugular venipuncture into 10-mL Vacutainer tubes (Fisher Scientific, Pittsburgh, PA). Following collection, blood samples were placed in ice and centrifuged at 1,500 g for 20 min at 4 °C within 2 to 4 h after collection. Plasma was decanted and stored at -20°C until analysis. Plasma concentrations of P4 were determined using a commercially available RIA kit (Coat-a-Count Progesterone; Siemens, Los Angeles, CA) as previously described from our laboratory (Burke et al., 2003) . Average intra-assay CV was 1.59%, interassay CV (4 assays) for pooled plasma samples containing 0.13, 1.12, and 3.17 ng/mL of P4 were 5.1, 3.2, and 2.4%, respectively, and the average sensitivity of the assays was 0.09 ng/mL. Pregnancy diagnosis was performed between 32 and 38 d after TAI by transrectal ultrasonography.
Data and Statistical Analyses
Pregnancy rate to TAI was defined as the number of heifers diagnosed pregnant at the first pregnancy diagnosis after TAI divided by the total number of heifers submitted to TAI. The GLIMIX procedure (SAS Inst. Effects of AI sire, AI technician, treatment, and the appropriate interactions on TAI pregnancy rate were initially evaluated within location and no interactions with treatment were detected. For the final analysis of pregnancy rate to TAI, location was included as a random effect and the initial model included only treatment. To analyze visual estrus response (yes or no) the model included treatment, pubertal status, and the interaction. The model to assess estrus distribution (interval from PGF 2α to estrus [n = 151]) and TPS distribution included treatment. To analyze the proportion of heifers that had failed luteolysis, the model included treatment. To analyze the effect of diameter of the largest follicle on d 0 (n = 151) and presence of a new CL (n = 294), the model included treatment, year, puberty status, and all the appropriate interactions. The model to test the effect of TPS on pregnancy to TAI included treatment, TPS, and the interaction. If a main effect was found to be significant (P ≤ 0.05), mean separation was conducted using the LS Means function of SAS. In an ancillary analysis, the effect of the presence of a newly formed CL on d 0 (n = 294) on estrous response and TAI pregnancy rates was evaluated. The initial model included treatment, presence of a new CL (yes or no), and their interaction. Terms with a significance value of P > 0.20 were removed from the complete model in a stepwise manner to derive the final reduced model for each variable. Differences were considered to be significant when P ≤ 0.05 and a tendency when 0.05 < P ≤ 0.10.
RESULTS
At CIDR withdrawal, presence of a new CL (Table 1) was greater (P < 0.01) in the GnRH+ (55.8%, 82/147) than GnRH-(26.5%, 39/147) treatment. For the Ohio-11 heifers (n = 151), pubertal status was determined and estrous expression was observed. Only 17.9% of heifers (27/151) were prepubertal and this proportion did not differ between treatments. Also, the proportion of heifers exhibiting estrus before TAI, mean interval from PGF 2α to estrus, and variance in estrous distribution did not differ between treatments (Table 1) . However, diameter of the largest follicle on d 0 (Table 1) was greater (P = 0.014) in the GnRH-than in the GnRH+ treatment (10.4 ± 0.4 and 9.0 ± 0.4 mm, respectively). Incidence of Luteolysis failure (P4 ≥ 0.5 ng/mL on d 3), 4 % 3.4 0.7 0.14 a,b There was not a TPS × treatment interaction on TAI pregnancy rates; however, the main effect of TPS was significant (P < 0.01). Heifers with a TPS of either 1 or 2 had greater (P < 0.01) TAI pregnancy rate than heifers receiving a TPS of 3, regardless treatments.
1 CL = corpus luteum; TAI = timed AI; P4 = progesterone.
2 GnRH+ = Heifers received 100 μg of GnRH at CIDR insertion.
3 GnRH-= Heifers did not receive GnRH at CIDR insertion. 4 Data collected in heifers used in Ohio in 2011 (Ohio-11) and 2012 (Ohio-12; n = 294).
5 Data collected in Ohio-11 (n = 151).
6 Data collected in all locations (n = 823).
7 Data collected in Ohio-11, Ohio-12, and heifers used in Idaho in 2012 (Idaho-12; n = 421).
8 TPS: 1 = paint completely removed, 2 = paint disturbed by mounting and partially removed, and 3 = paint largely undisturbed and no evidence of mounting.
9 TPS distribution was not affected by treatment.
failed luteolysis was evaluated in Ohio-11 and Ohio-12 (n = 294) and did not differ between treatments (GnRH+, 5/147, and GnRH-, 1/147). In heifers receiving tail paint at PGF 2α (n = 421), distribution of TPS did not differ (P = 0.52) between treatments (Table 1) . Pregnancy rate to TAI did not differ (P = 0.20) between treatments (Fig. 2) . Although location was included in the statistical model as a random effect, Fig. 3 illustrates only TAI pregnancy rates obtained at each location between treatments. A TPS × treatment interaction was not observed for TAI pregnancy rate; however, TPS did affect TAI pregnancy rates. Heifers with a TPS of either 1 or 2 had greater (P < 0.01) TAI pregnancy rate than heifers receiving a TPS of 3, regardless of treatments (Table 1 ). An ancillary analysis was performed with heifers from Ohio-11 and Ohio-12 to determine if the presence of a new CL at CIDR removal affected TAI pregnancy rates. In this analysis, no interaction between treatment and presence of a new CL on d 0 for TAI pregnancy rate and estrus response were detected (Table 1) . Across treatments, pregnancy rate to TAI tended (P = 0.057) to be greater in heifers with a new CL on d 0 (58.7%, 71/121) than in heifers lacking a new CL on d 0 (48.6%, 84/173).
DISCUSSION
The main objective of this study was to determine the necessity of GnRH (GnRH-1) at the initiation of the 5-d CO-Synch + CIDR protocol in beef heifers. This question was addressed primarily as a result of previous reports demonstrating that the proportion of heifers that ovulate to GnRH-1 is only 23 to 55% (Macmillan and Thatcher, 1991; Pursley et al., 1995; Vasconcelos et al., 1999; Moreira et al., 2000; Lamb et al., 2006; Atkins et al., 2008; Rabaglino et al., 2010a) . Furthermore, previous reports (Rabaglino et al., 2010a; Lima et al., 2011; Kasimanickam et al., 2014) in beef and dairy heifers yielded mixed conclusions as to the necessity of GnRH-1. In the present study, TAI pregnancy rates were similar in beef heifers that received or did not receive GnRH-1, suggesting that GnRH-1 administration is not required in the 5-d CO-Synch + CIDR protocol. The difference in response to the 2 treatments was marginal as GnRH administration only increased the proportion of heifers that had a new CL at CIDR removal by 29.3 % points. Of interest, irrespective of treatment, heifers that had a new CL on d 0 tended to have greater TAI pregnancy rates than heifers without a new CL. This suggests that fertility was improved in heifers that initiated a new fol- ; n = 294), and BS 3 was collected to determine failure in luteolysis in Ohio-11 and Ohio-12 (n = 294). Transrectal ultrasonography (US) was performed on d -5 to detected the presence of a spontaneous CL (US 1 ) in Ohio-12 (n = 143) and US 2 was performed on d 0 to identify the presence of a newly formed CL (Ohio-11 and Ohio-12; n = 294) and to determine the diameter of the largest follicle (Ohio-11; n = 151). Pregnancy diagnosis to timed AI (TAI) was performed via ultrasonography between d 32 and 38 after TAI depending on location. licular wave around the time of CIDR insertion, regardless of whether this was a spontaneous wave or one induced by GnRH. Increased pregnancy rates to TAI in females that respond to GnRH-1 compared to those that do not has been previously reported in beef cows that received the 7-d COSynch protocol (Geary et al., 1998) and in lactating dairy cows treated with the Ovsynch protocol (Vasconcelos et al., 1999; Santos et al., 2010) . This response, however, is not consistent across all investigations as both Stevenson (2008) and Lima et al. (2011) reported that TAI pregnancy rates in dairy heifers were not impacted by response to GnRH-1. Based on cumulative consideration of previous reports and findings in the present experiment, it appears that presence of a new CL at CIDR removal may be an important determinant of conception to TAI in beef heifers. However the relatively low response to GnRH-1 masked the potential benefits of this event in the present experiment. Perhaps the inconsistency among reports addressing this question may be due to variation in response to the initial GnRH among experiments.
A secondary objective of this study was to determine if a single 25-mg dose of PGF 2α was sufficient to induce luteolysis in beef heifers synchronized with the 5-d protocol. The presence of a greater number of heifers with a new CL on d 0 in the GnRH+ treatment did not affect the capacity of the single PGF 2α to induce luteal regression. The question of whether 1 or 2 doses of PGF 2α are necessary when synchronizing heifers with the 5-d CO-Synch + CIDR protocol has been addressed in multiple studies. Rabaglino et al. (2010a) reported similar TAI pregnancy rates with 1 versus 2 doses of PGF 2α in dairy heifers synchronized with the 5-d CO-Synch + CIDR protocol when GnRH-1 was given. More recently, Lima et al. (2013) reported similar TAI pregnancy rates in dairy heifers between 1 and 2 doses of PGF 2α when GnRH-1 was omitted. In addition, experiments in dairy heifers (Rabaglino et al., 2010a,b; Lima et al., 2011) have demonstrated that a single dose of PGF 2α was sufficient when used in a variety of derivations of the 5-d protocol. Peterson et al. (2011) reported that pregnancy rates tended (P = 0.06) to be greater when 2 doses of PGF 2α were given 6 h apart than when only a single dose of PGF 2α was administered to beef heifers synchronized with the 5-d protocol including GnRH-1, but a herd × treatment interaction in this report indicates this conclusion must be interpreted with caution. In a recent study where heifers either received or did not receive GnRH-1; and heifers either received 1or 2 doses of PGF 2α in the 5-d protocol (Kasimanickam et al., 2014) reported similar TAI pregnancy between treatments in dairy heifers (n = 1,137). In beef heifers (n = 1,018), PGF 2α dosage did not influence pregnancy rate to TAI in heifers that received GnRH at CIDR insertion. Therefore, with the exception of a single paper (Peterson et al., 2011) , no difference in TAI pregnancy rate between a single or multiple doses of PGF 2α have been confirmed with the 5-d CO-Synch + CIDR protocol in beef or dairy heifers. Likewise, the present experiment clearly demonstrates that the proportion of heifers that fail to undergo complete luteolysis following a single administration of PGF 2α in the 5-d protocol is approximately 3% and not affected by delivery or omission of GnRH-1. Therefore, based on the insignificant occurrence of luteolysis failure in this study, the use of a single PGF 2α dose at CIDR removal may be an effective treatment to promote luteal regression in yearling beef heifers that receive the 5-d CO-Synch + CIDR protocol, regardless of whether or not the GnRH-1 is given.
The interval from CIDR withdrawal to TAI with the 5-d CO-Synch + CIDR protocol used in the present experiment was 72 h, which is consistent with previous reports in beef (Wilson et al., 2007; Bridges et al., 2008; Perry et al., 2012) and dairy (Rabaglino et al., 2010a; Santos et al., 2010; Lima et al., 2011) cattle. Recently, Kasimanickam et al. (2012) demonstrated that TAI pregnancy rate was n = 137) . GnRH+ = at CIDR insertion heifers received 100 μg of GnRH; GnRH-= at CIDR insertion heifers did not receive GnRH.
increased by 10.3% points if TAI was performed at 56 h rather than 72 h after CIDR withdrawal in a 5-d COSynch + CIDR protocol when 2 doses of PGF 2α were given at CIDR withdrawal. It is unknown in the present study if pregnancy rates would have been increased with a shorter interval between CIDR withdrawal and TAI. However, based primarily on data from Kasimanickam et al. (2012) and observations of estrus distribution in the present study (48.2 h for both treatments), it appears that TAI 60 ± 4 h after CIDR withdrawal may be optimal in yearling beef heifers.
In conclusion, fertility of yearling beef heifers submitted to the 5-d CO-Synch + CIDR with a single PGF 2α was not affected by administration or omission of the initial GnRH at CIDR insertion. The incidence of new CL was increased by only 29% points with inclusion of GnRH-1. This relative poor response may be responsible for the lack of difference in TAI pregnancy rate between treatments in the present experiment. These findings suggest that the magnitude of the presumed benefit of the GnRH-1 treatment in beef heifers enrolled in the 5-d CO-Synch + CIDR protocol may be primarily determined by the proportion of heifers that ovulate in response to this treatment.
